Margaret Faul oversees drug substance technologies and has spent more than two decades at Amgen. She moved to Cambridge just ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results